Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. - Wikidata - wikimedia - TriplyDB

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.

http://www.wikidata.org/entity/Q39135519

about

Cancer and radiation therapy: current advances and future directions.Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial.Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.Current concepts in clinical radiation oncology.Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.The potential role of magnetic resonance spectroscopy in image-guided radiotherapy.Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer.Faculty of Radiation Oncology Position Paper on the use of Image-Guided Radiation Therapy.Reducing radiation-associated toxicity using online image guidance (IGRT) in prostate cancer patients undergoing dose-escalated radiation therapy.Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study.First Australian experience of treating localised prostate cancer patients with CyberKnife stereotactic radiotherapy: early PSA response, acute toxicity and quality of life.Image-guided radiation therapy: Physician's perspectives.Development of CBCT-based prostate setup correction strategies and impact of rectal distension.Seminal vesicle intrafraction motion analysed with cinematic magnetic resonance imaging.Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy.Hypofractionated helical tomotherapy using 2.5-2.6 Gy daily fractions for localized prostate cancer.Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer.Image-guided radiation therapy: looking beyond what we currently see.Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.Assessment of cone beam CT registration for prostate radiation therapy: fiducial marker and soft tissue methods.Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications.Image-guided radiotherapy for prostate cancer

P2860

Q35816527-89025E93-C5DE-49EA-B9DB-4FBAC37C1D3A Q36300055-0C8B9357-C9AA-4269-A497-B86875F286CB Q37110245-2B6D9DB2-2993-4E1C-8368-80D2F9C2514C Q37580538-4A29D7D0-A9EC-4587-A48F-4A2503422629 Q37603804-A39A21E4-3890-43EC-BE8D-EE97AB7C8CD9 Q38180344-FE160115-009A-409F-859A-70BCE5595CD1 Q38213398-7ECFF3D0-C57A-4546-B987-69C58D4D0A5C Q38362692-31B7AD70-036A-4F44-9185-226982EE4BF3 Q38819438-533EDB0F-21D2-4F24-8348-240BDAEABD98 Q39415628-D025F7AA-F6C9-4376-A4DA-4F5FDC90FC4C Q40070594-246220FC-14F5-47ED-B73E-0EE90A9EC4A3 Q40374784-B5A022CF-84C4-45E5-B46E-9DD2DC73A8E6 Q41633448-F99E8CC0-8684-409E-9CD0-915F8FAC2EFE Q41773467-CDA2E234-6E3E-4BB8-BE6C-D2845CAB446E Q41950829-27610D3C-CAA2-4383-BAF1-F68C992EFFCE Q42016724-C8FF5D7D-C81D-4E15-A37A-4A83B5EBE1B5 Q42256057-778844D0-5069-42CC-BC81-E7B7F373D17E Q44852521-32F27968-B272-46DA-8694-2D1B36144349 Q47145428-054760F8-A298-4680-983B-3EBD1BE9A8D3 Q47848625-755E235D-0165-4634-9BE2-C7EB3FD98697 Q48113512-0DEA5F47-2599-4860-AE7E-FE0D46DB93DC Q53147440-CCFF8A0D-1E2B-496E-B28F-FED58BBE026A Q55279439-03D6F4A4-1CB6-4DAE-A102-066EEDE1CF74 Q57112512-DD1285FB-F0BE-4AE9-B3E0-312F9D8137FD

P2860

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.

http://www.wikidata.org/entity/Q39135519

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Acute toxicity in prostate can ...... out image-guided radiotherapy.

@en

Acute toxicity in prostate can ...... out image-guided radiotherapy.

@nl

type

label

Acute toxicity in prostate can ...... out image-guided radiotherapy.

@en

Acute toxicity in prostate can ...... out image-guided radiotherapy.

@nl

prefLabel

Acute toxicity in prostate can ...... out image-guided radiotherapy.

@en

Acute toxicity in prostate can ...... out image-guided radiotherapy.

@nl

P1433

Q39135519-E126A649-661D-4FA8-800A-44A326AE8B37

P1476

Q39135519-A5B5520D-5794-480E-BAC5-D2C4BE9EE32B

P2093

Q39135519-3838D69B-ACA4-4FA0-BF88-CAC6C6251CF6

Q39135519-55545C4D-6AE6-44D8-9841-9BC2A03F7921

Q39135519-77A69FA8-6B58-4AE5-A5EF-E760D9B9880C

Q39135519-B312F745-06E2-40B5-9409-1A803D31C680

Q39135519-C2D8E609-F060-4614-B527-D3DBEF859470

Q39135519-CBC6FD60-4CA3-4FBB-BF52-8D09FB089E20

Q39135519-DF855B0E-C065-4735-B36C-E6C7B64C9BA4

Q39135519-FA362A30-0F8B-4A80-9B66-FD7A9D9A729B

P2860

Q39135519-020F0644-F744-490A-9906-A36E7C8638CD

Q39135519-064640D9-6F6A-4221-BE56-C9FE7EF8AD11

Q39135519-0CB1B847-D990-46B0-8805-C5EA4D307910

Q39135519-174AFB44-A1E2-43E1-AEE8-0576B7E46732

Q39135519-1BE54F88-01A6-4461-AEE1-D86612047FC1

Q39135519-1C35026C-CB4E-4B93-9DA1-9A0F6DD92EF1

Q39135519-4BBE0F8B-C127-4701-AA8C-3C43338EC9C3

Q39135519-56EBDB36-32C0-4C8F-9D98-08AA6178B6DC

Q39135519-593AF0B6-2B53-4065-B73C-E474DBE00AEC

Q39135519-5DCC45D7-647E-4FFD-B9A2-F48C532CCF91

P2888

Q39135519-33264D13-D27F-4BFB-97F6-129267FCA15A

P304

Q39135519-836DFD30-660B-4F66-8E5F-6E8633271B56

P31

Q39135519-573C02C0-F2AF-458F-B6F9-B0694AB1826A

P356

Q39135519-DD1FCA5F-917E-4ADB-BC3E-1511D5640584

P478

Q39135519-BC74A05F-3ACA-4730-9269-E5C973ACA125

P50

Q39135519-4CF23F34-DEDF-4BBA-8D54-4401DD63AA53

Q39135519-53A65E3D-A5BE-42D5-BEB3-162074C7B071

Q39135519-6553C146-D035-41DE-AE12-23ECC3FC3642

P577

Q39135519-AF486F5B-4735-47CF-ADE1-2F8D51C3126D

P5875

Q39135519-9DF151B5-2689-4168-920C-CF6C1B9E483D

P6179

Q39135519-3DE83E5A-1E76-4D4C-BDD1-5E7D2FBD1EB5

P698

Q39135519-BBF79233-B999-4CBD-8E8D-BD1920F62558

P921

Q39135519-770BBDCB-1897-4871-8C33-9D98EC695891

P932

Q39135519-7315274E-C3A0-4A9E-86AD-C6A52ADB5841

P356

1748-717X-6-145

P1433

Radiation Oncology

P1476

Acute toxicity in prostate can ...... out image-guided radiotherapy.

@en

P2093

Aldo Rolfo

http://www.w3.org/2001/XMLSchema#string

Farshad Foroudi

http://www.w3.org/2001/XMLSchema#string

Jessica Thomas

http://www.w3.org/2001/XMLSchema#string

Keen Hun Tai

http://www.w3.org/2001/XMLSchema#string

Mary Leahy

http://www.w3.org/2001/XMLSchema#string

Sarat Chander

http://www.w3.org/2001/XMLSchema#string

Scott Williams

http://www.w3.org/2001/XMLSchema#string

Suki Gill

http://www.w3.org/2001/XMLSchema#string

P2860

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study.

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials.

Extraction of data for margin calculations in prostate radiotherapy from a commercial record and verify system.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients

Image-guided radiotherapy for localized prostate cancer: treating a moving target.

P2888

1748-717x-6-145

P304

145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-6-145

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Gillian Duchesne

P577

2011-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51754793

http://www.w3.org/2001/XMLSchema#string

P6179

1000485841

http://www.w3.org/2001/XMLSchema#string

P698

22035354

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3217047

http://www.w3.org/2001/XMLSchema#string